Amir Schricker is a Cardiology physician affiliated with Sutter Health. OpenAlex indexes 76 publications with 1,234 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1501 Trousdale Dr
Burlingame, CA 940104506
Telephone
650-652-8600Provider last certified this registry record 7 Jun 2023.
Clinical trials
- Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms
Sponsor: University of California, San Diego
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20257 payments
- AtriCure, Inc.Program year20256 payments
- Boston Scientific CorporationProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.4%Antiarrhythmic21.1%Dofetilide54%Amiodarone Hcl22%Flecainide Acetate18%Multaq7%Part D<11 patientsBeta blocker20.5%Metoprolol Succinate48%Sotalol23%Sotalol Af14%Carvedilol11%Metoprolol Tartrate4%Part D<11 patients+ 4 more classes in this area
Blood & clotting
46.6%Factor Xa inhibitor44.7%Eliquis92%Xarelto8%Part D≥165 patientsDirect thrombin inhibitors1.9%Pradaxa52%Dabigatran Etexilate48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Failure of Transmural Posterior Wall Isolation by Pulse Field Ablation Demonstrated With Epicardial Mapping
JACC. Clinical electrophysiology
2025 - Esophageal cooling vs luminal esophageal temperature monitoring in high-power short-duration ablation of paroxysmal atrial fibrillation
Journal of Interventional Cardiac Electrophysiology
2025 - Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
Journal of the American College of Cardiology
2024 - Atrioesophageal Fistula Rates Before and After Adoption of Active Esophageal Cooling During Atrial Fibrillation Ablation
JACC. Clinical electrophysiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Milani, MD
Sutter Health
Roger Winkle, MD
Sutter Health
Powell Jose, MD
Sutter Health
David Bonovich, MD
Sutter Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”